Optimal Medical Therapy for Coronary Artery Disease in 2011- Perspectives from the STICH Trial

E-ISSN： 1875-6182|9|4|269-276

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.9, Iss.4, 2011-10, pp. : 269-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 4-9

Bentham Science Publishers

Access to resources Recommend Favorite

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Endothelin in coronary artery disease

By Pernow John

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 5, 2004-10 ,pp. : 257-258

Informa Healthcare

Access to resources Recommend Favorite

Vectorelectrocardiography in Coronary Artery Disease

By Dellborg Mikael

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 2, 2001-03 ,pp. : 72-74

Informa Healthcare

Access to resources Recommend Favorite

Inflammation and Coronary Artery Disease

Current Vascular Pharmacology, Vol. 1, Iss. 1, 2003-03 ,pp. : 65-70

Bentham Science Publishers

Access to resources Recommend Favorite